Dergiler / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 3

Investigation of the Effects of Edaravone on Valproic Acid Induced Tissue Damage in Pancreas

Sayfa
570–577
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, edaravone may be effective in moderation and/or reduction of toxic effects of VPA on pancreas.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Valproic acid (VPA), an effective antiepileptic and anticonvulsant drug, has some toxic side effects due to causing elevated oxidant production.
📊
Temel Bulgular & Veri:In VPA given group, LPO and SA levels, and ALP, TF, MPO activities significantly increased and GST, CAT, GPx activities significantly decreased compared to control group.
💡
Sonuç & Katkı:Therefore, edaravone may be effective in moderation and/or reduction of toxic effects of VPA on pancreas.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Valproic acid (VPA), an effective antiepileptic and anticonvulsant drug, has some toxic side effects due to causing elevated oxidant production. The aim of this study is to investigate the effects of edaravone, a potent free radical scavenger on VPA induced toxicity and tissue damage by biochemical and histological examinations on pancreas. Female Sprague Dawley rats were divided into four groups as follows; control, edaravone, VPA, VPA+edaravon. VPA and edaravone were injected intraperitonally for seven days. Total protein, lipid peroxidation (LPO), sialic acid (SA) and glutathione (GSH) levels and alkaline phosphatase (ALP), tissue factor (TF), superoxide dismutase (SOD), glutathione-S-transferase (GST), catalase (CAT), glutathione peroxidase (GPx) and myeloperoxidase (MPO) activities were determined in pancreas homogenates. In VPA given group, LPO and SA levels, and ALP, TF, MPO activities significantly increased and GST, CAT, GPx activities significantly decreased compared to control group. A marked morphological damage was detected in the VPA group. Ameliorative effects of edaravone were observed in SA, TF, CAT, GPx parameters and histological examination in the VPA group. Therefore, edaravone may be effective in moderation and/or reduction of toxic effects of VPA on pancreas.

🔖

Bu Makaleye Atıf Yap

OKTAY, S. (2017). Investigation of the Effects of Edaravone on Valproic Acid Induced Tissue Damage in Pancreas. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 3, 570–577. https://ajindex.com/articles/283666

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Iasemidis LD. Seizure prediction and its application. Neurosurg Clin N Am 2011; 22: 489-506
  2. Brodie MJ, Barry SJE, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012; 78: 1548-54
  3. Gerstner T, Büsing D, Bell N, Longin E, Kasper JM, Klostermann W, Hebing B, Hanefeld F, Eckel U, Hoffman R, Bettendorf U, Weidner B, Wiemer-Kruel A, Brockmann K, Neumann FW, Sandriese T, Wolff M, König S. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. J Gastroenterol 2007; 42: 39-48
  4. Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neur 2012; 11: 792-802
  5. Belcastro V, D’Egidio C, Striano P, Verrotti A. Metabolic and endocrine effects of valproic acid chronic treatment. Epilepsy Res 2013; 107: 1-8
  6. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Anthony F, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott P, Wijdicks EFM. Guidelines for the early management of adults with ischemic stroke. Stroke 2007; 38: 1655-711
  7. Xi H, Akishita M, Nagai K, Yu W, Hasegawa H, Eto M, Kozaki K, Toba K. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis 2007; 191: 281-9
  8. Kikuchi K, Tancharoen S, Takeshiga N, Yoshitomi M, Morioka M, Murai Y, Tanaka E. The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease. Int J Mol Sci 2013; 14: 13909-30
  9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193; 265-75
  10. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1981; 105: 328-37
  11. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234: 1971-5
  12. Beutler E. Gluthatione: red cell metabolism. A manual biochemical methods. New York: Grune and Stratton, 1975, pp:112-14
  13. Walter K, Schült C. Acid and alkaline phosphatase in serum (two point method) In Methods of enzymatic Analysis Ed: Bergmeyer HU, 2nd ed. FL, 1974, pp:856-86
  14. Ingram GIC, Hills M. Reference method for the one stage prothrombin time test on human blood. Thromb Haemostas 1976; 36: 237-8
  15. Mylorie AA, Collins H, Umbles C, Kyle J. Erythrocyte SOD activity and other parameters of copper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 1986; 82: 512-20
  16. Habig WH, Jacoby WB. Assays for differentation of gluta